ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Primary Myelofibrosis (PMF) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0Z14273
Home | Market Reports | Health| Health Conditions| Cancer
Global Primary Myelofibrosis PMF Market Research Report 2023
BUY CHAPTERS

Global Primary Myelofibrosis (PMF) Market Research Report 2025

Code: QYRE-Auto-0Z14273
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
AbbVie
Novartis
Celgene
Grunenthal
Incyte
CTI BioPharma
Bristol–Myers Squibb
Suzhou Zelgen Biopharmaceuticals

Primary Myelofibrosis (PMF) Market Size

The global market for Primary Myelofibrosis (PMF) was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 290 million by 2031, growing at a CAGR of 9.6% during the forecast period.

Primary Myelofibrosis (PMF) Market

Primary Myelofibrosis (PMF) Market

Primary myelofibrosis (MF) is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells. Researchers believe MF may be caused by abnormal blood stem cells in the bone marrow. The abnormal stem cells produce mature cells that grow quickly and take over the bone marrow, causing both fibrosis (scar tissue formation) and chronic inflammation. The statistic scope is primary myelofibrosis drug in this report.
North American market for Primary Myelofibrosis (PMF) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Primary Myelofibrosis (PMF) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Primary Myelofibrosis (PMF) include GSK, AbbVie, Novartis, Celgene, Grunenthal, Incyte, CTI BioPharma, Bristol Myers Squibb, Suzhou Zelgen Biopharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Primary Myelofibrosis (PMF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Myelofibrosis (PMF).
The Primary Myelofibrosis (PMF) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Primary Myelofibrosis (PMF) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Primary Myelofibrosis (PMF) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Primary Myelofibrosis (PMF) Market Report

Report Metric Details
Report Name Primary Myelofibrosis (PMF) Market
Accounted market size in year US$ 154 million
Forecasted market size in 2031 US$ 290 million
CAGR 9.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • JAK 1
  • JAK 2
  • Others
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, AbbVie, Novartis, Celgene, Grunenthal, Incyte, CTI BioPharma, Bristol Myers Squibb, Suzhou Zelgen Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Primary Myelofibrosis (PMF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Primary Myelofibrosis (PMF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Primary Myelofibrosis (PMF) Market growing?

Ans: The Primary Myelofibrosis (PMF) Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the Primary Myelofibrosis (PMF) Market size in 2031?

Ans: The Primary Myelofibrosis (PMF) Market size in 2031 will be US$ 290 million.

Who are the main players in the Primary Myelofibrosis (PMF) Market report?

Ans: The main players in the Primary Myelofibrosis (PMF) Market are GSK, AbbVie, Novartis, Celgene, Grunenthal, Incyte, CTI BioPharma, Bristol Myers Squibb, Suzhou Zelgen Biopharmaceuticals

What are the Application segmentation covered in the Primary Myelofibrosis (PMF) Market report?

Ans: The Applications covered in the Primary Myelofibrosis (PMF) Market report are Adults, Children

What are the Type segmentation covered in the Primary Myelofibrosis (PMF) Market report?

Ans: The Types covered in the Primary Myelofibrosis (PMF) Market report are JAK 1, JAK 2, Others

Recommended Reports

Blood Cancer Drugs

Hematology Disease Markets

Fibrosis & Related Therapies

1 Primary Myelofibrosis (PMF) Market Overview
1.1 Product Definition
1.2 Primary Myelofibrosis (PMF) by Type
1.2.1 Global Primary Myelofibrosis (PMF) Market Value Comparison by Type (2024 VS 2031)
1.2.2 JAK 1
1.2.3 JAK 2
1.2.4 Others
1.3 Primary Myelofibrosis (PMF) by Application
1.3.1 Global Primary Myelofibrosis (PMF) Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Primary Myelofibrosis (PMF) Market Size Estimates and Forecasts
1.4.1 Global Primary Myelofibrosis (PMF) Revenue 2020-2031
1.4.2 Global Primary Myelofibrosis (PMF) Sales 2020-2031
1.4.3 Global Primary Myelofibrosis (PMF) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Primary Myelofibrosis (PMF) Market Competition by Manufacturers
2.1 Global Primary Myelofibrosis (PMF) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Primary Myelofibrosis (PMF) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Primary Myelofibrosis (PMF) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Primary Myelofibrosis (PMF), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Primary Myelofibrosis (PMF), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Primary Myelofibrosis (PMF), Product Type & Application
2.7 Global Key Manufacturers of Primary Myelofibrosis (PMF), Date of Enter into This Industry
2.8 Global Primary Myelofibrosis (PMF) Market Competitive Situation and Trends
2.8.1 Global Primary Myelofibrosis (PMF) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Primary Myelofibrosis (PMF) Players Market Share by Revenue
2.8.3 Global Primary Myelofibrosis (PMF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Primary Myelofibrosis (PMF) Market Scenario by Region
3.1 Global Primary Myelofibrosis (PMF) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Primary Myelofibrosis (PMF) Sales by Region: 2020-2031
3.2.1 Global Primary Myelofibrosis (PMF) Sales by Region: 2020-2025
3.2.2 Global Primary Myelofibrosis (PMF) Sales by Region: 2026-2031
3.3 Global Primary Myelofibrosis (PMF) Revenue by Region: 2020-2031
3.3.1 Global Primary Myelofibrosis (PMF) Revenue by Region: 2020-2025
3.3.2 Global Primary Myelofibrosis (PMF) Revenue by Region: 2026-2031
3.4 North America Primary Myelofibrosis (PMF) Market Facts & Figures by Country
3.4.1 North America Primary Myelofibrosis (PMF) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Primary Myelofibrosis (PMF) Sales by Country (2020-2031)
3.4.3 North America Primary Myelofibrosis (PMF) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Primary Myelofibrosis (PMF) Market Facts & Figures by Country
3.5.1 Europe Primary Myelofibrosis (PMF) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Primary Myelofibrosis (PMF) Sales by Country (2020-2031)
3.5.3 Europe Primary Myelofibrosis (PMF) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Primary Myelofibrosis (PMF) Market Facts & Figures by Region
3.6.1 Asia Pacific Primary Myelofibrosis (PMF) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Primary Myelofibrosis (PMF) Sales by Region (2020-2031)
3.6.3 Asia Pacific Primary Myelofibrosis (PMF) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Primary Myelofibrosis (PMF) Market Facts & Figures by Country
3.7.1 Latin America Primary Myelofibrosis (PMF) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Primary Myelofibrosis (PMF) Sales by Country (2020-2031)
3.7.3 Latin America Primary Myelofibrosis (PMF) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Primary Myelofibrosis (PMF) Market Facts & Figures by Country
3.8.1 Middle East and Africa Primary Myelofibrosis (PMF) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Primary Myelofibrosis (PMF) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Primary Myelofibrosis (PMF) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Primary Myelofibrosis (PMF) Sales by Type (2020-2031)
4.1.1 Global Primary Myelofibrosis (PMF) Sales by Type (2020-2025)
4.1.2 Global Primary Myelofibrosis (PMF) Sales by Type (2026-2031)
4.1.3 Global Primary Myelofibrosis (PMF) Sales Market Share by Type (2020-2031)
4.2 Global Primary Myelofibrosis (PMF) Revenue by Type (2020-2031)
4.2.1 Global Primary Myelofibrosis (PMF) Revenue by Type (2020-2025)
4.2.2 Global Primary Myelofibrosis (PMF) Revenue by Type (2026-2031)
4.2.3 Global Primary Myelofibrosis (PMF) Revenue Market Share by Type (2020-2031)
4.3 Global Primary Myelofibrosis (PMF) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Primary Myelofibrosis (PMF) Sales by Application (2020-2031)
5.1.1 Global Primary Myelofibrosis (PMF) Sales by Application (2020-2025)
5.1.2 Global Primary Myelofibrosis (PMF) Sales by Application (2026-2031)
5.1.3 Global Primary Myelofibrosis (PMF) Sales Market Share by Application (2020-2031)
5.2 Global Primary Myelofibrosis (PMF) Revenue by Application (2020-2031)
5.2.1 Global Primary Myelofibrosis (PMF) Revenue by Application (2020-2025)
5.2.2 Global Primary Myelofibrosis (PMF) Revenue by Application (2026-2031)
5.2.3 Global Primary Myelofibrosis (PMF) Revenue Market Share by Application (2020-2031)
5.3 Global Primary Myelofibrosis (PMF) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Primary Myelofibrosis (PMF) Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie Primary Myelofibrosis (PMF) Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Primary Myelofibrosis (PMF) Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Celgene
6.4.1 Celgene Company Information
6.4.2 Celgene Description and Business Overview
6.4.3 Celgene Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Celgene Primary Myelofibrosis (PMF) Product Portfolio
6.4.5 Celgene Recent Developments/Updates
6.5 Grunenthal
6.5.1 Grunenthal Company Information
6.5.2 Grunenthal Description and Business Overview
6.5.3 Grunenthal Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Grunenthal Primary Myelofibrosis (PMF) Product Portfolio
6.5.5 Grunenthal Recent Developments/Updates
6.6 Incyte
6.6.1 Incyte Company Information
6.6.2 Incyte Description and Business Overview
6.6.3 Incyte Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Incyte Primary Myelofibrosis (PMF) Product Portfolio
6.6.5 Incyte Recent Developments/Updates
6.7 CTI BioPharma
6.7.1 CTI BioPharma Company Information
6.7.2 CTI BioPharma Description and Business Overview
6.7.3 CTI BioPharma Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CTI BioPharma Primary Myelofibrosis (PMF) Product Portfolio
6.7.5 CTI BioPharma Recent Developments/Updates
6.8 Bristol Myers Squibb
6.8.1 Bristol Myers Squibb Company Information
6.8.2 Bristol Myers Squibb Description and Business Overview
6.8.3 Bristol Myers Squibb Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol Myers Squibb Primary Myelofibrosis (PMF) Product Portfolio
6.8.5 Bristol Myers Squibb Recent Developments/Updates
6.9 Suzhou Zelgen Biopharmaceuticals
6.9.1 Suzhou Zelgen Biopharmaceuticals Company Information
6.9.2 Suzhou Zelgen Biopharmaceuticals Description and Business Overview
6.9.3 Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis (PMF) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis (PMF) Product Portfolio
6.9.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Primary Myelofibrosis (PMF) Industry Chain Analysis
7.2 Primary Myelofibrosis (PMF) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Primary Myelofibrosis (PMF) Production Mode & Process Analysis
7.4 Primary Myelofibrosis (PMF) Sales and Marketing
7.4.1 Primary Myelofibrosis (PMF) Sales Channels
7.4.2 Primary Myelofibrosis (PMF) Distributors
7.5 Primary Myelofibrosis (PMF) Customer Analysis
8 Primary Myelofibrosis (PMF) Market Dynamics
8.1 Primary Myelofibrosis (PMF) Industry Trends
8.2 Primary Myelofibrosis (PMF) Market Drivers
8.3 Primary Myelofibrosis (PMF) Market Challenges
8.4 Primary Myelofibrosis (PMF) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
AbbVie
Novartis
Celgene
Grunenthal
Incyte
CTI BioPharma
Bristol–Myers Squibb
Suzhou Zelgen Biopharmaceuticals
List of Tables
 Table 1. Global Primary Myelofibrosis (PMF) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Primary Myelofibrosis (PMF) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Primary Myelofibrosis (PMF) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Primary Myelofibrosis (PMF) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Primary Myelofibrosis (PMF) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Primary Myelofibrosis (PMF) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Primary Myelofibrosis (PMF) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Primary Myelofibrosis (PMF) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Primary Myelofibrosis (PMF), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Primary Myelofibrosis (PMF), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Primary Myelofibrosis (PMF), Product Type & Application
 Table 12. Global Key Manufacturers of Primary Myelofibrosis (PMF), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Primary Myelofibrosis (PMF) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Myelofibrosis (PMF) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Primary Myelofibrosis (PMF) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Primary Myelofibrosis (PMF) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Primary Myelofibrosis (PMF) Sales Market Share by Region (2020-2025)
 Table 19. Global Primary Myelofibrosis (PMF) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Primary Myelofibrosis (PMF) Sales Market Share by Region (2026-2031)
 Table 21. Global Primary Myelofibrosis (PMF) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Primary Myelofibrosis (PMF) Revenue Market Share by Region (2020-2025)
 Table 23. Global Primary Myelofibrosis (PMF) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Primary Myelofibrosis (PMF) Revenue Market Share by Region (2026-2031)
 Table 25. North America Primary Myelofibrosis (PMF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Primary Myelofibrosis (PMF) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Primary Myelofibrosis (PMF) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Primary Myelofibrosis (PMF) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Primary Myelofibrosis (PMF) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Primary Myelofibrosis (PMF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Primary Myelofibrosis (PMF) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Primary Myelofibrosis (PMF) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Primary Myelofibrosis (PMF) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Primary Myelofibrosis (PMF) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Primary Myelofibrosis (PMF) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Primary Myelofibrosis (PMF) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Primary Myelofibrosis (PMF) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Primary Myelofibrosis (PMF) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Primary Myelofibrosis (PMF) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Primary Myelofibrosis (PMF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Primary Myelofibrosis (PMF) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Primary Myelofibrosis (PMF) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Primary Myelofibrosis (PMF) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Primary Myelofibrosis (PMF) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Primary Myelofibrosis (PMF) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Primary Myelofibrosis (PMF) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Primary Myelofibrosis (PMF) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Primary Myelofibrosis (PMF) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Primary Myelofibrosis (PMF) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Primary Myelofibrosis (PMF) Sales (K Units) by Type (2020-2025)
 Table 51. Global Primary Myelofibrosis (PMF) Sales (K Units) by Type (2026-2031)
 Table 52. Global Primary Myelofibrosis (PMF) Sales Market Share by Type (2020-2025)
 Table 53. Global Primary Myelofibrosis (PMF) Sales Market Share by Type (2026-2031)
 Table 54. Global Primary Myelofibrosis (PMF) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Primary Myelofibrosis (PMF) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Primary Myelofibrosis (PMF) Revenue Market Share by Type (2020-2025)
 Table 57. Global Primary Myelofibrosis (PMF) Revenue Market Share by Type (2026-2031)
 Table 58. Global Primary Myelofibrosis (PMF) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Primary Myelofibrosis (PMF) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Primary Myelofibrosis (PMF) Sales (K Units) by Application (2020-2025)
 Table 61. Global Primary Myelofibrosis (PMF) Sales (K Units) by Application (2026-2031)
 Table 62. Global Primary Myelofibrosis (PMF) Sales Market Share by Application (2020-2025)
 Table 63. Global Primary Myelofibrosis (PMF) Sales Market Share by Application (2026-2031)
 Table 64. Global Primary Myelofibrosis (PMF) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Primary Myelofibrosis (PMF) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Primary Myelofibrosis (PMF) Revenue Market Share by Application (2020-2025)
 Table 67. Global Primary Myelofibrosis (PMF) Revenue Market Share by Application (2026-2031)
 Table 68. Global Primary Myelofibrosis (PMF) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Primary Myelofibrosis (PMF) Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Primary Myelofibrosis (PMF) Product
 Table 74. GSK Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AbbVie Primary Myelofibrosis (PMF) Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis Primary Myelofibrosis (PMF) Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Celgene Company Information
 Table 86. Celgene Description and Business Overview
 Table 87. Celgene Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Celgene Primary Myelofibrosis (PMF) Product
 Table 89. Celgene Recent Developments/Updates
 Table 90. Grunenthal Company Information
 Table 91. Grunenthal Description and Business Overview
 Table 92. Grunenthal Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Grunenthal Primary Myelofibrosis (PMF) Product
 Table 94. Grunenthal Recent Developments/Updates
 Table 95. Incyte Company Information
 Table 96. Incyte Description and Business Overview
 Table 97. Incyte Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Incyte Primary Myelofibrosis (PMF) Product
 Table 99. Incyte Recent Developments/Updates
 Table 100. CTI BioPharma Company Information
 Table 101. CTI BioPharma Description and Business Overview
 Table 102. CTI BioPharma Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CTI BioPharma Primary Myelofibrosis (PMF) Product
 Table 104. CTI BioPharma Recent Developments/Updates
 Table 105. Bristol Myers Squibb Company Information
 Table 106. Bristol Myers Squibb Description and Business Overview
 Table 107. Bristol Myers Squibb Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol Myers Squibb Primary Myelofibrosis (PMF) Product
 Table 109. Bristol Myers Squibb Recent Developments/Updates
 Table 110. Suzhou Zelgen Biopharmaceuticals Company Information
 Table 111. Suzhou Zelgen Biopharmaceuticals Description and Business Overview
 Table 112. Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis (PMF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis (PMF) Product
 Table 114. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Primary Myelofibrosis (PMF) Distributors List
 Table 118. Primary Myelofibrosis (PMF) Customers List
 Table 119. Primary Myelofibrosis (PMF) Market Trends
 Table 120. Primary Myelofibrosis (PMF) Market Drivers
 Table 121. Primary Myelofibrosis (PMF) Market Challenges
 Table 122. Primary Myelofibrosis (PMF) Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Primary Myelofibrosis (PMF)
 Figure 2. Global Primary Myelofibrosis (PMF) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Primary Myelofibrosis (PMF) Market Share by Type: 2024 & 2031
 Figure 4. JAK 1 Product Picture
 Figure 5. JAK 2 Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Primary Myelofibrosis (PMF) Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Primary Myelofibrosis (PMF) Market Share by Application: 2024 & 2031
 Figure 9. Adults
 Figure 10. Children
 Figure 11. Global Primary Myelofibrosis (PMF) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Primary Myelofibrosis (PMF) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Primary Myelofibrosis (PMF) Sales (2020-2031) & (K Units)
 Figure 14. Global Primary Myelofibrosis (PMF) Average Price (US$/Unit) & (2020-2031)
 Figure 15. Primary Myelofibrosis (PMF) Report Years Considered
 Figure 16. Primary Myelofibrosis (PMF) Sales Share by Manufacturers in 2024
 Figure 17. Global Primary Myelofibrosis (PMF) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Primary Myelofibrosis (PMF) Players: Market Share by Revenue in Primary Myelofibrosis (PMF) in 2024
 Figure 19. Primary Myelofibrosis (PMF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Primary Myelofibrosis (PMF) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Primary Myelofibrosis (PMF) Sales Market Share by Country (2020-2031)
 Figure 22. North America Primary Myelofibrosis (PMF) Revenue Market Share by Country (2020-2031)
 Figure 23. United States Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Primary Myelofibrosis (PMF) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Primary Myelofibrosis (PMF) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Primary Myelofibrosis (PMF) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Primary Myelofibrosis (PMF) Revenue Market Share by Region (2020-2031)
 Figure 34. China Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Primary Myelofibrosis (PMF) Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Primary Myelofibrosis (PMF) Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Primary Myelofibrosis (PMF) Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Primary Myelofibrosis (PMF) Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Primary Myelofibrosis (PMF) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Primary Myelofibrosis (PMF) by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Primary Myelofibrosis (PMF) by Type (2020-2031)
 Figure 53. Global Primary Myelofibrosis (PMF) Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Primary Myelofibrosis (PMF) by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Primary Myelofibrosis (PMF) by Application (2020-2031)
 Figure 56. Global Primary Myelofibrosis (PMF) Price (US$/Unit) by Application (2020-2031)
 Figure 57. Primary Myelofibrosis (PMF) Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Primary Myelofibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Primary Myelofibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Myelofibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Myelofibrosis Treatment Market Research Report 2024
Global Chronic Idiopathic Myelofibrosis Market Research Report 2024
Secondary Myelofibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Myelofibrosis Targeted Drug Market Research Report 2024
Myeloproliferative Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polycythemia Vera Treatment Drugs Market Research Report 2025
Blood Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Tumor Drugs Market Research Report 2024
Global Multiple Myeloma Treatment Market Research Report 2024
Global Myocardial Fibrosis Market Insights Forecast to 2030
Multiple Myeloma Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Cancer Treatments Market Research Report 2024
Global Blood Tumor Treatment Market Research Report 2024
Global Blood Cancer Therapeutics Market Insights Forecast to 2030
Global Chronic Myeloid Leukemia Treatment Drugs Market Research Report 2025
Pulmonary Fibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment of Skin Fibrosis Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions